Press Releases

Relevium Technologies Inc. announced its plans to increase its presence in Walmart.com and ramp up its current offering to over thirty (30) SKUs before the end of the year.

Relevium Technologies Inc. is pleased to announce that the Bioganix® brand is now available for purchase in the United Kingdom on the Amazon.co.uk platform.

Relevium Technologies Inc. is pleased to announce that it will be launching its first  organic whole hemp extract product line under the LeefyLyfe® brand in Europe and the United Kingdom.

Relevium Technologies Inc. is pleased to announce that the company’s wholly owned subsidiary Biocannabix has signed a lease agreement for the company’s anticipated 93,000 SQ. FT., vertically integrated facility located within 20 minutes of downtown Montreal, Quebec in Ville St-Laurent.

Relevium Technologies Inc. is pleased to announce that the Company has just launched five new BioganixⓇ products which are now live on both the native websites at Bioganix.com and Amazon.com.

Relevium Technologies Inc. is pleased to announce it has received final listing approval for its Bioganix® Gold Series Nutraceuticals on Walmart.com and the products are currently live and available for purchase.

July 30, 2018 - MONTREAL, QUEBEC – Relevium Technologies Inc. (TSX.V:  “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce it has received final listing approval for its Bioganix® Gold Series Nutraceuticals on Walmart.com...

Relevium Technologies Inc. is pleased to announce that the company’s wholly owned subsidiary Biocannabix Health Corporation has received an approval letter from the City of Ville St-Laurent (VSL), located in Montréal, Québec for the Company’s 93,000 SQ. FT. cultivation and fully integrated processing facility under the Access to Cannabis for Medical Purposes Regulations (ACMPR).

Relevium Technologies Inc. is pleased to announce it has appointed Mr. Faycal Salek CPA, CA as the Chief Financial Officer of the Company effective immediately.

Relevium Technologies Inc. is pleased to announce it has executed a supply agreement with Plena Global Holdings Inc., a Canadian based holding company accumulating medical marijuana grow production assets across legalized countries in South America, to supply full spectrum CBD oil to the company’s supply chain partners in Europe starting January 2019.

Relevium Technologies Inc. is pleased to announce it has put into production 920,000 soft-gels each of its Cardio-Metabolic Syndrome and Dry-Eye Syndrome formulations containing Provinal® Omega 7.

Relevium Technologies Inc. is pleased to announce the reduction of $2 million in debt through the conversion of the entire principal amount of USD $1.55M unsecured convertible debenture maturing next year on June 6, 2019.